CURX
Curanex Pharmaceuticals Inc Common Stock
There isn't enough reported data to score CURX yet.
CURX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
CURX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
CURX PE Valuation
CURX has no meaningful PE right now: it lost money over the past year.
CURX Forward outlook
There aren't enough analyst estimates for CURX to show an outlook.
CURX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$7.80 | -$7.53 |
| Q1 2026 | -$5.40 | -$5.10 |
| Q4 2025 | -$3.30 | -$3.04 |
| Q3 2025 | -$1.00 | -$0.83 |
CURX lost $7.80 per share over the past year, and its loss has widened in each of the last four quarters.
CURX Quarterly Revenue
CURX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$954.6K | -$804.6K |
CURX Net Leverage
CURX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CURX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.0 | Neutral |
| Stochastic | 64.1 | Neutral |
CURX's weekly RSI is 62 (neutral) and its Stochastic is 64 (neutral).
CURX PE vs Healthcare Sector
CURX has no meaningful PE right now: it lost money over the past year.
CURX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.13 | 11% above |
| 20 week MA | $4.71 | 20% above |
| 50 week MA | $6.33 | 10% below |
CURX has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 10% below its 50-week average.
CURX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $112.0 | $7.27 | -94% |
| 2026 YTD | $7.27 | $5.67 | -22% |
CURX has finished every year since 2025 lower, and it's down 22% so far in 2026.